Please use this identifier to cite or link to this item:
Title: Concentration-and pH-dependent oligomerization of the thrombin-derived C-terminal peptide TCP-25
Authors: Petruk, G.
Petrlova, J.
Samsudin, F.
Del Giudice, R.
Bond, P.J. 
Schmidtchen, A.
Keywords: Antimicrobial peptide
Peptide self-assembly
pH-and/or concentration-sensitive oligomerization
Issue Date: 2020
Publisher: MDPI AG
Citation: Petruk, G., Petrlova, J., Samsudin, F., Del Giudice, R., Bond, P.J., Schmidtchen, A. (2020). Concentration-and pH-dependent oligomerization of the thrombin-derived C-terminal peptide TCP-25. Biomolecules 10 (11) : 1-19. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Peptide oligomerization dynamics affects peptide structure, activity, and pharmacodynamic properties. The thrombin C-terminal peptide, TCP-25 (GKYGFYTHVFRLKKWIQKVIDQFGE), is currently in preclinical development for improved wound healing and infection prevention. It exhibits turbidity when formulated at pH 7.4, particularly at concentrations of 0.3 mM or more. We used biochemical and biophysical approaches to explore whether the peptide self-associates and forms oligomers. The peptide showed a dose-dependent increase in turbidity as well as ?-helical structure at pH 7.4, a phenomenon not observed at pH 5.0. By analyzing the intrinsic tryptophan fluorescence, we demonstrate that TCP-25 is more stable at high concentrations (0.3 mM) when exposed to high temperatures or a high concentration of denaturant agents, which is compatible with oligomer formation. The denaturation process was reversible above 100 µM of peptide. Dynamic light scattering demonstrated that TCP-25 oligomerization is sensitive to changes in pH, time, and temperature. Computational modeling with an active 18-mer region of TCP-25 showed that the peptide can form pH-dependent higher-order end-to-end oligomers and micelle-like structures, which is in agreement with the experimental data. Thus, TCP-25 exhibits pH-and temperature-dependent dynamic changes involving helical induction and reversible oligomerization, which explains the observed turbidity of the pharmacologically developed formulation. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: Biomolecules
ISSN: 2218273X
DOI: 10.3390/biom10111572
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_biom10111572.pdf2.67 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons